(Q48950462)

17 February 2018

title

Treatment costs for glioblastoma multiforme in Nova Scotia. (English)

1 reference

17 February 2018

1 reference

Mendez I

1

1 reference

17 February 2018

Jacobs P

series ordinal

2

1 reference

17 February 2018

MacDougall A

series ordinal

3

1 reference

17 February 2018

Schultz M

series ordinal

4

1 reference

17 February 2018

publication date

1 February 2001

1 reference

17 February 2018

Canadian Journal of Neurological Sciences

published in

1 reference

17 February 2018

volume

28

1 reference

17 February 2018

issue

1

1 reference

17 February 2018

page(s)

61-65

1 reference

17 February 2018

The costs of managing patients with malignant glioma at a neuro-oncology clinic.

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100052574

7 January 2021

Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100052574

7 January 2021

Cost and survival analysis of metastatic cerebral tumors treated by resection and radiation

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100052574

7 January 2021

Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100052574

7 January 2021

Management of primary malignant brain tumours

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100052574

7 January 2021

Medical care at the end of life: the interaction of economics and ethics

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100052574

7 January 2021

A cost-effectiveness and cost-utility analysis of radiosurgery vs. resection for single-brain metastases

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100052574

7 January 2021

High-grade astrocytomas: resource use, clinical outcomes, and cost of care.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100052574

7 January 2021

Decision framework for chemotherapeutic interventions for metastatic non-small-cell lung cancer.

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100052574

7 January 2021

Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100052574

7 January 2021

Trends in Medicare payments in the last year of life

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100052574

7 January 2021

The incidence and economic costs of cancer, motor vehicle injuries, coronary heart disease, and stroke: a comparative analysis

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100052574

7 January 2021

The basis for current treatment recommendations for malignant gliomas

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100052574

7 January 2021

The cost effectiveness of stereotactic radiosurgery versus surgical resection in the treatment of solitary metastatic brain tumors

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100052574

7 January 2021

Cost-utility analysis of a malignant glioma protocol

1 reference

https://api.crossref.org/works/10.1017%2FS0317167100052574

7 January 2021

10.1017/S0317167100052574

Identifiers

DOI

0 references

1 reference

17 February 2018